Delaying the Empiric Treatment of <i>Candida</i> Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

Antimicrobial Agents and Chemotherapy - Tập 49 Số 9 - Trang 3640-3645 - 2005
Matthew R. Morrell1, Victoria J. Fraser2, Marin H. Kollef1
1Pulmonary and Critical Care Division
2Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri 63110

Tóm tắt

ABSTRACT Fungal bloodstream infections are associated with significant patient mortality and health care costs. Nevertheless, the relationship between a delay of the initial empiric antifungal treatment until blood culture results are known and the clinical outcome is not well established. A retrospective cohort analysis with automated patient medical records and the pharmacy database at Barnes-Jewish Hospital was conducted. One hundred fifty-seven patients with a Candida bloodstream infection were identified over a 4-year period (January 2001 through December 2004). Fifty (31.8%) patients died during hospitalization. One hundred thirty-four patients had empiric antifungal treatment begun after the results of fungal cultures were known. From the time that the first blood sample for culture that was positive was drawn, 9 (5.7%) patients received antifungal treatment within 12 h, 10 (6.4%) patients received antifungal treatment between 12 and 24 h, 86 (54.8%) patients received antifungal treatment between 24 and 48 h, and 52 (33.1%) patients received antifungal treatment after 48 h. Multiple logistic regression analysis identified Acute Physiology and Chronic Health Evaluation II scores (one-point increments) (adjusted odds ratio [AOR], 1.24; 95% confidence interval [CI], 1.18 to 1.31; P < 0.001), prior antibiotic treatment (AOR, 4.05; 95% CI, 2.14 to 7.65; P = 0.028), and administration of antifungal treatment 12 h after having the first positive blood sample for culture (AOR, 2.09; 95% CI, 1.53 to 2.84; P = 0.018) as independent determinants of hospital mortality. Administration of empiric antifungal treatment 12 h after a positive blood sample for culture is drawn is common among patients with Candida bloodstream infections and is associated with greater hospital mortality. Delayed treatment of Candida bloodstream infections could be minimized by the development of more rapid diagnostic techniques for the identification of Candida bloodstream infections. Alternatively, increased use of empiric antifungal treatment in selected patients at high risk for fungal bloodstream infection could also reduce delays in treatment.

Từ khóa


Tài liệu tham khảo

10.1097/01.md.0000091182.93122.8e

10.1093/infdis/167.5.1247

10.1086/321811

Bross, J., G. H. Talbot, G. Maislin, S. Jurwitz, and B. L. Strom. 1989. Risk factors for nosocomial candidemia: a case control study. Am. J. Med.87:614-620.

Concato, J., A. R. Feinstein, and T. R. Holford. 1993. The risk of determining risk with multivariate models. Ann. Intern. Med.118:201-210.

10.1097/01.CCM.0000085089.88077.AF

10.1097/00003246-199906000-00019

10.1097/01.CCM.0000098031.24329.10

10.1128/JCM.42.4.1519-1527.2004

10.1016/j.amjmed.2003.07.005

10.1001/archsurg.137.12.1353

10.1378/chest.118.1.146

10.1097/00003246-200106000-00003

Karabinis, A., C. Hill, B. Leclerg, C. Tancrede, D. Baume, and A. Andremont. 1998. Risk factors for candidemia in cancer patients: a case-control study. J. Clin. Microbiol.26:429-432.

10.1097/00003246-198510000-00009

10.1093/clinids/11.3.379

10.1086/313890

10.7326/0003-4819-134-4-200102200-00014

10.1378/chest.115.2.462

10.1378/chest.113.2.412

Kullberg, B. J., and A. M. Oude Lashof. 2002. Epidemiology of opportunistic invasive mycoses. Eur. J. Med. Res.7:183-191.

10.1086/421956

10.1016/S1525-1578(10)60498-9

10.1128/AAC.49.4.1306-1311.2005

10.1056/NEJMoa021585

10.1378/chest.125.2.607

10.1086/344058

10.1128/JCM.40.10.3551-3557.2002

10.1128/JCM.36.7.1886-1889.1998

10.1128/AAC.44.3.747-751.2000

10.1002/pmic.200400903

10.1164/ajrccm.156.1.9607030

Richet, H. M., A. Andremont, C. Tancrede, J. L. Pico, and W. R. Jarvis. 1991. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev. Infect. Dis.13:211-215.

Schwartz, R. S., F. R. Mackintosh, S. L. Schrier, and P. L. Greenberg. 1984. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer53:411-419.

10.1128/JCM.39.3.949-953.2001

10.1007/s10096-004-1128-2

10.1093/infdis/168.1.195

10.1128/jcm.32.9.2103-2106.1994

10.1093/clind/24.4.584

10.1001/archinte.1989.00390100145030

Wiley, J. M., N. Smith, B. G. Leventhal, M. L. Graham, L. C. Strauss, C. A. Hurwitz, J. Modlin, D. Mellits, R. Baumgardner, B. J. Corben, and C. I. Civin. 1990. Invasive fungal disease in pediatric acute leukemia with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. J. Clin. Oncol.8:280-286.

10.1086/421946

Thông tin
Thông tin xuất bản

Antimicrobial Agents and Chemotherapy

Tập 49 Số 9

3640-3645

Thông tin tác giả